HOME >> MEDICINE >> NEWS
Philanthropist Paul F. Glenn launches labs for aging research at Harvard Medical School

ern the pace at which normal individuals experience physiological decline and disease. "As we mark our 40th anniversary, we are very excited to establish this important relationship with Harvard Medical School and look forward to accelerating research into this important area" said Mark R. Collins, President of the Glenn Foundation.

Historically financial support for research into the biological mechanisms of aging and efforts to extend the healthy lifespan has been spotty. The pharmaceutical industry's support of basic aging research is hindered due to the fact that there are no generally accepted biomarkers for aging that would allow the FDA to approve a drug designed to slow the aging process. Although Congress supplemented scarce aging research dollars by establishing the National Institute on Aging in 1974, that money has predominately gone to disease specific research, such as Alzheimer's disease, or towards the behavioral aspects of aging. "Instead of addressing individual age related diseases, we are looking at the bigger picture. Being able to extend the normal healthy lifespan has huge societal impact including decreasing associated healthcare costs and increasing the productive lifespan. By understanding the basic mechanisms of aging, we hope to altogether avoid or mitigate the onset of age related diseases as demonstrated by the research in caloric restriction," said Mr. Glenn. "Recent discoveries of longevity genes by Dr. Sinclair and others have persuaded me that aging includes the phenomenon of a small group of genes controlling the expression of a much larger group of genes, including those which activate cellular defense mechanisms such as DNA repair. As we learn to control expression of specific genes, we may be able to prolong healthy cell life without a complete understanding of the biochemical pathways involved."

In addition to funding these important initiatives through the creation of the Paul F. Glenn Laboratories at Ha
'"/>

Contact: John Lacey
public_affairs@hms.harvard.edu
617-432-0442
Harvard Medical School
11-Mar-2005


Page: 1 2 3 4 5

Related medicine news :

1. Brookhaven lab scientist wins Glenn T. Seaborg Award for Nuclear Chemistry
2. International breast cancer prevention study launches in the United States and Canada
3. UNH launches 2nd spinout company with NIH grants
4. The European Society of Cardiology launches Women at Heart
5. Euroscience Open Forum 2006 launches call for proposals
6. eDocAmerica launches Hispanic Website for members
7. Binghamton University launches microelectronics research center
8. NIH launches new study to compare prostate surgery and drugs
9. NIAID launches influenza genome sequencing project
10. University of Pennsylvania Health System launches life-saving eICU technology
11. NIAID launches program to improve medical tools against emerging infectious diseases

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2020)... ... May 21, 2020 , ... In ... will be lifted on May 28th and all businesses will be required to ... returning back to work. , As an essential business, AmeriCare Medical began this ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... health management platform that supports care management and utilization management at health insurance ... client sites, TruCare 2020 provides significant usability and automation upgrades to all of ...
(Date:5/17/2020)... ... May 18, 2020 , ... R3 Stem Cell International is ... clinic. There are two program options for patients and their families, which are ... is unclear exactly what causes Autism Spectrum Disorder (ASD), there are several recent ...
(Date:5/16/2020)... ... May 15, 2020 , ... KUDO Inc., ... the Open Source Medical Supplies (OSMS). The organization will obtain free access to ... the spread of COVID-19. , Created as a response to the COVID-19 pandemic ...
(Date:5/15/2020)... ... ... Collagen has taken the areas of beauty and anti-aging by storm, up by ... Nutritional Outlook ‘Ingredients to Watch’ US forecast. Collagen ingredients have matured in front of ... low-impact products of the past to the clinically-studied, low-molecular weight hydrolysates of today. , ...
Breaking Medicine News(10 mins):
(Date:5/21/2020)... Ore. (PRWEB) , ... May ... ... May 2020 , Guests: Kevin Kearns, Boston, Massachusetts, founder/CEO of Burn with ... IDEA, the world’s largest association for fitness and wellness professional & competitive ...
(Date:5/21/2020)... ... , ... Labyrinthe Labs has announced the launch of its brand new and ... designed for fast-action relief of joint and muscle soreness, Lefa is botanically powered by ... joints and muscles. , According to the National Institutes of Health , ...
(Date:5/16/2020)... ... May 17, 2020 , ... ... professionals, who in collaboration with a physician, can provide primary care, injury ... diagnosis, therapeutic intervention, and rehabilitation of injuries and medical conditions. Secondary schools ...
Breaking Medicine Technology:
Cached News: